Table 1.
Parameters | COVID-19 patients | Control subjects | Reference range | ||
---|---|---|---|---|---|
X ± SD | Range | X ± SD | Range | ||
WBC (× 109/l) | 10.18 ± 3.33 | 6.95–21.58 | 6.7 ± 1.0 | 5.3–8.21 | 3.7–10.0 |
Granulocytes (× 109/l) | 8.38 ± 3.36 | 5.09–20.15 | 3.84 ± 1.01 | 2.4–6.27 | 2.1–6.5 |
Lymphocytes (× 109/l) | 1.10 ± 0.55 | 0.42–2.17 | 2.23 ± 0.48 | 1.4–3.1 | 1.2–3.4 |
Monocytes (× 109/l) | 0.63 ± 0.39 | 0.12–1.93 | 0.58 ± 0.14 | 0.4–0.75 | 0.1–0.8 |
AST (IU/l) | 38.91 ± 27.29 | 14–117 | 14.8 ± 9.2 | 6–37 | 0.0–40.0 |
LDH (U/l) | 630.95 ± 145.02 | 361–826 | 213.2 ± 79.2 | 125–354 | 220–450 |
CRP (mg/l) | 63.95 ± 68.47 | 5.9–317.7 | 1.4 ± 0.4 | < 1.0–2.0 | < 5 |
IL-6 (pg/ml) | 39.13 ± 26.48 | 11.2–111.4 | n.d. | n.d. | < 6 |
PCT (ng/ml) | 0.15 ± 0.37 | 0.04–1.78 | n.d. | n.d. | 0.5–2.0 |
WBC white blood cells, AST aspartate aminotransferase, LDH lactate dehydrogenase, CRP C-reactive protein, IL-6 interleukin 6, PCT procalcitonin, n.d. not determined